Cargando…
Efficacy of coronavirus disease 2019 vaccines in patients with rheumatic diseases
OBJECTIVES: In this study, we report the immune response to the BNT162b2 vaccine and CoronaVac vaccine after a two-dose vaccination and the effects of conventional drugs, immunosuppressive drugs, and new-generation therapies on vaccine responses in patients with rheumatic and musculoskeletal disease...
Autores principales: | Taştekin, Fatih, Taşbakan, Meltem, Çiçek, Candan, Soylu, Mehmet, Yargucu Zihni, Figen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Turkish League Against Rheumatism
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689018/ https://www.ncbi.nlm.nih.gov/pubmed/38046249 http://dx.doi.org/10.46497/ArchRheumatol.2023.9676 |
Ejemplares similares
-
Retrospective Evaluation of COVID-19 Infection and COVID-19 Vaccines in Heart Transplant Patients
por: Kahraman, Ümit, et al.
Publicado: (2023) -
Interstitial cystitis: a rare manifestation of primary Sjögren’s syndrome, successfully treated with low dose cyclosporine
por: Emmungil, Hakan, et al.
Publicado: (2011) -
Laboratory evaluation in rheumatic diseases
por: Birtane, Murat, et al.
Publicado: (2017) -
Acceptability of Vaccines Against Preventable Infections Including Coronavirus Disease 2019 Among Patients With Rheumatic Disease
por: Tedeschi, Sara K., et al.
Publicado: (2021) -
Safety and reported adverse effects of coronavirus disease-2019 (COVID-19) vaccines in patients with rheumatic diseases
por: Aboud, Fatma M., et al.
Publicado: (2023)